Quotient Investors’s Usana Health Sciences USNA Stock Holding History

Quotient Investors’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$213K	Hold	3,700	–	–	0.15%	130
2017 Q2	$237K	Sell	3,700 -6,800	-65%	-$419K	0.17%	123
2017 Q1	$605K	Buy	+10,500	New	+$627K	0.36%	89
2014 Q2	–	Sell	-43,800	Closed	-$1.65M	–	275
2014 Q1	$1.65M	Buy	+43,800	New	+$1.53M	0.38%	88
2013 Q4	–	Sell	-5,400	Closed	-$234K	–	270
2013 Q3	$234K	Buy	+5,400	New	+$217K	0.06%	223

Other funds holding USNA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quotient Investors's USNA Position: Q3 2017 in Review

Quotient Investors held its Usana Health Sciences (USNA) position steady in Q3 2017 at 3,700 shares worth $213K. The position accounts for 0.15% of the portfolio, ranked #130.

Quotient Investors first reported a position in USNA in Q3 2013 and has held it in 5 quarters since. The position peaked at $1.65M in Q1 2014. 144 funds tracked by Wall St. Rank hold USNA as of Q3 2017.

Quotient Investors held 3,700 shares of Usana Health Sciences worth $213K as of Q3 2017.
Quotient Investors left its Usana Health Sciences share count unchanged in Q3 2017.
Usana Health Sciences made up 0.15% of Quotient Investors's portfolio in Q3 2017, its #130 holding.
Quotient Investors first reported a position in Usana Health Sciences in Q3 2013 and has held it in 5 quarters since.
Quotient Investors's Usana Health Sciences position peaked at $1.65M in Q1 2014.
144 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2017.

Based on Quotient Investors's 13F filing for Q3 2017, filed 18 Oct 2017.